Interestingly, for six genes (KISS1, CXCR4, PSMB9, ABCB1, FGF2, and IL6) found to be up-regulated along with GCS, their overexpression pursuant to platinum-agent treatments in patients promoted resistance to those same agents in cancers (Figure 4B). Here, FGF2 is linked to cancer.